300 related articles for article (PubMed ID: 24448199)
1. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice.
Morgan LA; Olzinski AR; Upson JJ; Zhao S; Wang T; Eisennagel SH; Hoang B; Tunstead JR; Marino JP; Willette RN; Jucker BM; Behm DJ
J Cardiovasc Pharmacol; 2013 Apr; 61(4):291-301. PubMed ID: 23232840
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
6. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
7. Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.
Ai D; Shyy JY; Zhu Y
Kidney Int; 2010 Jan; 77(2):88-92. PubMed ID: 19847158
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
11. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
[TBL] [Abstract][Full Text] [Related]
13. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.
Ai D; Pang W; Li N; Xu M; Jones PD; Yang J; Zhang Y; Chiamvimonvat N; Shyy JY; Hammock BD; Zhu Y
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):564-9. PubMed ID: 19126686
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
Agocha A; Lee HW; Eghbali-Webb M
J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
[TBL] [Abstract][Full Text] [Related]
19. High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.
Lin L; Gong H; Ge J; Jiang G; Zhou N; Li L; Ye Y; Zhang G; Ge J; Zou Y
Biochem Biophys Res Commun; 2011 Jan; 404(1):28-33. PubMed ID: 21094634
[TBL] [Abstract][Full Text] [Related]
20. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]